• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA指数作为乳腺癌的预后因素。

DNA index as prognostic factor in breast cancer.

作者信息

Rzymowska J, Skierski J, Kurylcio L, Dyrda Z

机构信息

Department of Cell Biology, Maria Sklodowska-Curie University, Lublin, Poland.

出版信息

Neoplasma. 1995;42(5):239-42.

PMID:8552202
Abstract

Enzymatically dissociated cells exhibited growth in most cases while mechanically dissociated cells did not grow in short term cultures and were not suitable for cytometric study. Breast cancer cells obtained by enzymatic dissociation were examined for DNA content and S-phase fraction. The most of the primary and metastatic breast cancer cells were aneuploid. The 74% rate of invasive and 62% of primary breast cancers had aneuploid (> G0/G1) DNA content, 22% of metastatic breast cancer cells and 37% of primary tumors cells were DNA diploid or near diploid tumor stemlines. The means of DNA diploid and near diploid tumor cells were higher in primary tumors. DNA index was higher in more aggressive and metastatic tumors. S-phase fractions were higher in cells of metastatic tumors than those in primary tumors. Nuclear DNA content and S-phase fraction can be considered a valuable prognostic indicators in breast cancer.

摘要

大多数情况下,酶解细胞能够生长,而机械解离的细胞在短期培养中无法生长,不适合进行细胞计数研究。对通过酶解获得的乳腺癌细胞进行了DNA含量和S期比例检测。大多数原发性和转移性乳腺癌细胞为非整倍体。74%的浸润性乳腺癌和62%的原发性乳腺癌具有非整倍体(> G0/G1)DNA含量,22%的转移性乳腺癌细胞和37%的原发性肿瘤细胞为DNA二倍体或近二倍体肿瘤干细胞系。原发性肿瘤中DNA二倍体和近二倍体肿瘤细胞的平均值更高。在侵袭性更强和转移性肿瘤中,DNA指数更高。转移性肿瘤细胞的S期比例高于原发性肿瘤细胞。核DNA含量和S期比例可被视为乳腺癌中有价值的预后指标。

相似文献

1
DNA index as prognostic factor in breast cancer.DNA指数作为乳腺癌的预后因素。
Neoplasma. 1995;42(5):239-42.
2
Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.流式细胞术与乳腺癌中Ki67标记指数的比较:181例病例的前瞻性评估
Anticancer Res. 2002 Jan-Feb;22(1A):295-8.
3
Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.包括DNA直方图类型、受体含量以及分期在内的预后指标与人类乳腺癌患者的生存情况相关。
Cancer Res. 1984 Sep;44(9):4187-96.
4
Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.通过图像和流式细胞术分析S期分数在淋巴结阴性乳腺癌中的预后价值。
Mod Pathol. 1997 Mar;10(3):216-22.
5
Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Oncol Rep. 2002 Jul-Aug;9(4):793-9.
6
Hypoploidy defines patients with poor prognosis in breast cancer.
Oncol Rep. 2007 May;17(5):1109-14.
7
Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.在检测细胞角蛋白标记的肿瘤细胞后,通过流式细胞术对卵巢癌中DNA倍性和S期分数的预后意义进行多变量分析。
Gynecol Oncol. 2002 Jan;84(1):21-31. doi: 10.1006/gyno.2001.6440.
8
Predictive value of flow cytometry for metastatic potential in breast cancer.
Am Surg. 1999 May;65(5):434-8.
9
[Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].[乳腺癌与流式细胞术:DNA倍体模式与临床病理参数的比较研究]
Rev Med Chil. 1994 Jun;122(6):643-52.
10
Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.复发性人垂体腺瘤的流式细胞术DNA倍体及细胞周期分数。流式细胞术分析与增殖细胞核抗原表达的相关性研究。
Gen Diagn Pathol. 1996 Oct;142(2):89-95.

引用本文的文献

1
Exploring cancer register data to find risk factors for recurrence of breast cancer--application of Canonical Correlation Analysis.探索癌症登记数据以寻找乳腺癌复发的风险因素——典型相关分析的应用
BMC Med Inform Decis Mak. 2005 Aug 22;5:29. doi: 10.1186/1472-6947-5-29.